KPOC yields 400000.00% · ABBV yields 3.06%● Live data
📍 KPOC pulled ahead of the other in Year 1
Combined, KPOC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KPOC + ABBV for your $10,000?
Kimberly Parry Organics Inc. manufactures and distributes spa and resort products. It offers organic skin care, organic bath and body, organic mom and baby care, gift, manicure/pedicure and prenatal, and organic spa treatment products. The company serves retail and professional markets; and sells its products online. Kimberly Parry Organics Inc. distributes its products through 500 outlets, including CosmeKitchen locations in Japan; Beauty Gallery locations in Macau; Great Jones Spa in New York; Four Seasons Resorts in Las Vegas and Santa Barbara; Terranea Resort & Spa in California; Ascent Spa at Tenaya Lodge, California; and other retail outlets across the United States. The company was formerly known as VizStar, Inc. and changed its name to Kimberly Parry Organics Inc. in April 2014. Kimberly Parry Organics Inc. was founded in 1999 and is based in San Clemente, California.
Full KPOC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.